tradingkey.logo

OraSure Technologies Inc reports results for the quarter ended June 30 - Earnings Summary

ReutersAug 5, 2025 9:43 PM
  • OraSure Technologies Inc OSUR.OQ reported a quarterly adjusted loss of 26 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -1 cents. The mean expectation of three analysts for the quarter was for a loss of 20 cents per share. Wall Street expected results to range from -21 cents to -20 cents per share.

  • Revenue fell 42.5% to $31.24 million from a year ago; analysts expected $30.36 million.

  • OraSure Technologies Inc's reported EPS for the quarter was a loss of 26 cents​.

  • The company reported a quarterly loss of $19.69 million.

  • OraSure Technologies Inc shares had risen by 4.0% this quarter and lost 13.6% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 20.6% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"

  • Wall Street's median 12-month price target for OraSure Technologies Inc is $6.00, about 48% above its last closing price of $3.12

This summary was machine generated from LSEG data August 5 at 09:43 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Jun. 30 2025

-0.20

-0.26

Missed

Mar. 31 2025

-0.20

-0.21

Missed

Dec. 31 2024

-0.06

-0.14

Missed

Sep. 30 2024

-0.08

-0.06

Beat

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
KeyAI